In Vitro Effects of two Gold Compounds, and D-Penicillamine on the Producn of Interferon Gamma
- 1 January 1990
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 12 (1) , 39-60
- https://doi.org/10.3109/08923979009006460
Abstract
There are contradictory reports on Interferon Gamma (IFN.gamma.) production by peripheral blood mononuclear cells (PBMC) in rheumatoid arthritis (RA). Since many patients previously studied were on Gold Sodium Thiomalate (GST), Auranofin (Auf), or D-Penicillamine (D-Pen) we have investigated the effects of these drugs on IFN.gamma. production using PBMC from normal controls (NC), and RA patients off GST, Auf, and D-Pen. Auf in low concentrations enhanced IFN.gamma. production by PBMC from NC but not RA; GST, and D-Pen had no effect. In other experiments PBMC were stimulated with concanavalin A (CONA A), or phytohemagglutinin (PHA). Auf, and GST inhibited IFN.gamma. production by CON A - stimulated NC and RA cells; D-Pen had no effect. Auf in low concentrations enhanced IFN.gamma. production by PHA-stimulated NC cells, but this effect was not seen with RA cells; GST inhibited both RA and NC cell production of IFN.gamma., and D-Pen had no effect. Auf has a biphasic effect on TFN.gamma. production by NC cells with low concentrations being stimulatory or co-stimulatory, possibly by acting on T helper cells. Higher concentrations of Auf and GST, equivalent to those achieved in vivo in the course of therapy, inhibit IFN.gamma. production. These results suggest that gold therapy may affect IFN.gamma. production in RA, and could explain discrepancies noted in previous studies.This publication has 19 references indexed in Scilit:
- Stimulatory effects of anti-rheumatic drugs on human neutrophil functionsImmunopharmacology, 1988
- Interferon-Gamma, the Activated Macrophage, and Host Defense Against Microbial ChallengeAnnals of Internal Medicine, 1988
- Impaired Mitogen‐Induced Interferon‐γ Production in Rheumatoid Arthritis and Related DiseasesScandinavian Journal of Immunology, 1988
- Production of Tumour Necrosis Factor-a, Interferon-y and lnterleukin-2 by Peripheral Blood Mononuclear Cells of Subjects Suffering from Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1988
- Interferons and rheumatoid arthritis: insight into interferon biology?Immunology Today, 1987
- Results of a phase-II clinical trial on treatment of rheumatoid arthritis with recombinant interferon-gammaRheumatology International, 1987
- In vitro effects of thymopentin on the γ-interferon production by peripheral blood mononuclear cells from normal subjects and from patients with rheumatoid arthritisImmunology Letters, 1987
- Reduced Production of Interferon Alpha and Interferon Gamma in Leukocyte Cultures from Patients with Active Rheumatoid ArthritisScandinavian Journal of Rheumatology, 1987
- Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon.Proceedings of the National Academy of Sciences, 1984
- Preliminary criteria for clinical remission in rheumatoid arthritisArthritis & Rheumatism, 1981